First Interstate Bank Novo Nordisk A S Transaction History

First Interstate Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$63.69 - $70.22 $323,481 - $356,647	-5,079 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $25,055 - $29,078	-428 Reduced 7.77%	5,079 $333,000
Q1 2020 May 11, 2020	SELL	$49.46 - $64.78 $131,613 - $172,379	-2,661 Reduced 32.58%	5,507 $332,000
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $40,885 - $47,773	-820 Reduced 9.12%	8,168 $473,000
Q3 2019 Oct 30, 2019	SELL	$47.54 - $53.43 $36,986 - $41,568	-778 Reduced 7.97%	8,988 $465,000
Q2 2019 Aug 05, 2019	SELL	$46.79 - $52.47 $41,970 - $47,065	-897 Reduced 8.41%	9,766 $498,000
Q3 2018 Nov 07, 2018	SELL	$46.76 - $51.24 $31,095 - $34,074	-665 Reduced 5.87%	10,663 $503,000
Q2 2018 Jul 27, 2018	SELL	$44.29 - $50.42 $69,535 - $79,159	-1,570 Reduced 12.17%	11,328 $522,000
Q1 2018 Apr 26, 2018	SELL	$48.49 - $58.14 $68,710 - $82,384	-1,417 Reduced 9.9%	12,898 $635,000
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $53,091 - $60,016	-1,117 Reduced 7.24%	14,315 $768,000
Q3 2017 Nov 08, 2017	BUY	$41.15 - $49.22 $635,026 - $759,563	15,432	15,432 $743,000

1,876

318M

5.49M

7.77M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $191B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

Stay updated on First Interstate Bank with notifications on news.